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We constructed an infectious molecular clone of acquired immunodeficiency syndrome-associated retrovirus. 
Upon transfection, this clone directed the production of infectious virus particles in a wide variety of cells in 
addition to human T4 cells. The progeny, infectious virions, were synthesized in mouse, mink, monkey, and 
several human non-T cell lines, indicating the absence of any intracellular obstacle to viral RNA or protein 
production or assembly. During the course of these studies, a human colon carcinoma cell line, exquisitely 
sensitive to DNA transfection, was identified. 
A group of T-lymphotropic retroviruses (RVs), with a 
genomic structure characteristic of lentiviruses (34), has 
been isolated from patients with acquired immunodeficiency 
syndrome (AIDS), AIDS-related complex, and generalized 
lymphadenopathy (2, 9, 23). During its propagation in vitro, 
the virus selectively infects and ultimately kills the subset of 
human T lymphocytes exhibiting the OKT4-Leu-3 pheno- 
type (7, 20), the same cells that are profoundly affected in 
individuals suffering from the disease (14, 15). 
Mechanisms responsible for cell- and species-specific tro- 
pism(~) have been studied in a number of retroviral systems. 
For both avian and murine RVs, restriction affecting the 
interaction of the viral envelope glycoprotein and a specific 
cell receptor has been demonstrated repeatedly and is re- 
sponsible for the unique host range of xenotropic and 
ecotropic mouse leukemia viruses (for a review, see refer- 
ence 36). In the murine system, at least, retroviral restriction 
or tropism may also be determined at a point subsequent to 
adsorption and penetration. For example, the thymotropism 
exhibited by many mink cell focus-forming murine leukemia 
viruses very likely reflects the properties of enhancer ele- 
ments present within the long terminal repeats of these 
recombinant murine leukemia viruses (5). Furthermore, Fv-I 
(29) restriction involves the interaction of viral capsid pro- 
teins (18, 19, 31) and certain cell component(s) during the 
early phase of infection. 
In this report, the potential restriction of AIDS RV repli- 
cation in non-T4 lymphocytes was evaluated. Because the 
transfection of an infectious molecular clone of the AIDS RV 
provirus would bypass any barrier imposed by the interac- 
tion of virus particles with their receptors, intracellular 
restriction affecting the expression of viral genes can be 
readily examined. Cloned AIDS RV DNA was introduced 
into 3 human lymphoid, 11 human nonlymphoid, and 3 
nonhuman cell lines. The progeny, infectious virions, were 
detected in 14 of the 17 transfected cell lines, indicating the 
absence of any intracellular obstacle to viral RNA or protein 
synthesis and assembly. 
* Corresponding author. 
MATERIALS AND METHODS 
Cells. The cell lines used in these studies are listed in Table 
1. The three human lymphoid cell lines were propagated and 
maintained in RPMI 1640 medium supplemented with heat- 
inactivated (56°C for 30 min) 10% fetal calf serum. The 
adherent cell lines listed in Table 1 were cultured in 
Dulbecco modified Eagle minimal essential medium contain- 
ing heat-inactivated 10% fetal calf serum. Normal human 
peripheral blood lymphocytes (PBLs) were cryopreserved 
and stored in liquid nitrogen until needed. Before use, the 
PBLs were quickly thawed, washed, and prepared for infec- 
tion as described previously (2). 
Construction of an infectious molecular clone. The origin of 
the NY5 and LAV AIDS RV isolates has been outlined 
previously (2, 3). Molecular clones of integrated NY5 and 
LAV proviruses were obtained from bacteriophage lambda 
DNA libraries constructed from EcoRI-restricted prepara- 
tions of virus-infected PBLs. NY5 proviral DNA, like other 
North American isolates, contained a single EcoRI site at 5.7 
kilobases (kb) and was cloned as two separate restriction 
fragments containing either 5' or 3' flanking cellular DNA. 
Integrated NY5 proviruses, cloned in EcoRI-digested A 
Charon 4A (4), were identified by hybtidization to 32P- 
labeled pBenn6, which contains 6.5-kb AIDS RV sequences 
mapping between 1.7 and 8.2 kb (8). Molecular clones 
containing sequences located 3' to the EcoRI site at 5.7 kb of 
LAV proviral DNA were isolated from a AJ1 (28) library 
after hybridization with 32P-labeled pBenn4 (8). The cloned 
NY5 and LAV proviruses were then transferred to EcoRI- 
digested pUC18 and subsequently used to construct full- 
length clones. 
Transfection assays. Nonlymphoid and lymphoid cells 
were transfected by the calcium phosphate precipitation (16, 
37) and electroporation (30) techniques, respectively, with 
10 kg of uncleaved plasmid DNA in each assay. Virus 
production was monitored in non-T4 cells by cocultivation 
with CD4+ A3.01 cells (lo6 cells of each type) 2 days after 
transfection. Reverse transcriptase (RT) assays were carried 
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co- ~ i l -  reference 
culture trate 
Human T-cell leukemia 
Human B-cell lympho- 
ma (EBV- 1' 
Human B-cell lympho- 





Human melanoma cells 
Human pancreatic car- 
cinoma cells 
Human ovarian carci- 
noma cells 
Human breast carci- 
noma cells 
Human colon carci- 
noma cells 
Human colon carci- 
noma cells 
Human colon carci- 
noma cells 
Human colon carci- 
noma cells 
Human rectal carci- 
noma cells 
Mink lung epithelial 
cells 
Monkey kidney cells 
transformed by sim- 
ian virus 40 
Mouse fibroblast cells 
- ND ATCC CCL86 
+ + ATCC HTB82 
- ND 1 
+ ND 39 
+ + ATCC HTB79 
+ + ATCC HTB77 
- ND 39 
+ + ATCC HTB37 
+ ND ATCC HTB39 
ND + ATCC HTB38 
ND + ATCC CCL228 
ND + ATCC CCL234 
+ ND ATCC CCL64 
+ + 12 
+ ND ATCC CCL92 
" + .  Production: -, no production. ND. Not determined 
EBV-, Epstein-Barr virus negative. 
E B V + ,  Epstein-Barr virus positive. 
out at various times after cocultivation as described previ- 
ously (8). 
In situ hybridization. Transfected cell preparations were 
sedimented onto polylysine-coated glass slides, fixed in 
periodate-lysine-paraformaldehyde-glutaradehyde and pre- 
treated with HCI and proteinase K to allow the labeled probe 
to enter the cells (10, 11). Cells were prehybridized in 10 mM 
Tris (pH 7.4)-2x standard saline citrate (SSC) ( l x  SSC is 
0.15 M NaCl plus 0.015 M sodium citrate [pH 7.41)-50% 
formamide-lx Denhardt solution (0.02% polyvinylpyr- 
rol idone,  0.02% Ficoll [Pharmacia Fine Chemicals .  
Piscataway, N.J.], 0.02% bovine serum albumin)-200 pg of 
yeast tRNA per ml at 4S°C for 2 h and were hybridized in this 
solution plus 10% dextran sulfate, 5 pM dithiothreitol, and 
lo6 cpm of 35S-labeled AIDS RV RNA in 10-pl reaction 
mixtures. Subgenomic viral DNA fragments present in pB1 
(3), pBenn6 (8), p B l l  (3), and a recombinant plasmid (pRG- 
B) which contains a 1.35-kb Hind111 fragment mapping 
between 8.25 and 9.6 kb on the proviral DNA were 
subcloned into SP6lT7 vectors (Promega Biotec, Madison, 
Wis.), and the pooled DNAs were transcribed with "S- 
labeled UTP (Amersham Corp.,  Arlington Heights, Ill.). The 
labeled RNAs were incubated with 40 FM NaHC03-60 pM 
Na2C03 [pH 10.21 before hybridization to facilitate their 
entry into cells. 
Hybridization was performed at  45°C for 8 h. The samples 
were then washed in 2 x  SSC at 22°C for 10 min, with two 
changes; 2 x  SSC-O.l% Triton X-100 at  60°C for 30 min; 2 x  
SSC plus RNase A (40 pglml) and RNase T I  (10 Ulml) at 
37°C for 30 min; and 2 x  SSC at 60°C for 10 min. All solutions 
except those with RNase A contained 5 pM dithiothreitol 
and 1 pM EDTA. Autoradiography was performed for 1 to 2 
days as  described previously (11). 
CAT assays. Chloramphenicol acetyltransferase (CAT) 
assays with pSV2CAT DNA have been described previously 
(13). The uptake of pSV2CAT DNA into transfected cells 
was monitored by dot blot hybridization using 32P-labeled 
pUC18 DNA. 
RESULTS 
Construction of full-length clones of the AIDS RV provirus. 
Our previous experience indicated that only a minority of 
cloned murine leukemia virus proviral DNAs were infectious 
after their introduction into susceptible cells. Therefore, we 
decided to take advantage of the single EcoRI site that 
virtually bisected (located at 5.7 kb) the proviruses of North 
American AIDS RV isolates (3), and we elected to mix and 
match 5'  and 3' halves of integrated proviral DNAs that had 
been obtained from different infected cellular DNA libraries. 
Representative examples are shown in the top portion of Fig. 
1. AN5' consisted of a 20.2-kb EcoRI fragment in A Charon 
4A that was cloned from a library of NYS-infected PBLs. 
AL3 and AL4 were isolated from LAV-infected cellular DNA 
preparations with a 3' AIDS RV probe and consisted of 7.5- 
and 13.6-kb EcoRI inserts, respectively, in a AJ1 phage 
vector. An 8.3-kb BnnzHI-EcoRI subclone of AN5' was 
introduced into BnmHI-EcoRI-digested pUC18 to generate a 
plasmid designated pN5'. Because pN5' contained a single 
EcoRI site, EcoRI fragments containing the 3' half of the 
AIDS RV provirus could be readily introduced, thereby 
generating full-length and potentially infectious constructs. 
The EcoRI segments from AL3 (both orientations) and AL4 
were inserted into pN5' (Fig. 1). Of note is the presence of a 
unique HincIII site at 8.7 kb in pNL4-3; a HincII site at this 
position (representing a restriction enzyme site polymor- 
phism in the parental LAV virus stock) had been previously 
identified in an isolate from Alabama (3). 
Infectivity of full-length AIDS RV proviral DNA con- 
structs was monitored after electroporation into A3.01 cells. 
We have previously reported that the A3.01 cell line is >95% 
Leu-3' Leu-8' Leu- l+  and is exquisitely sensitive to  AIDS 
RV infection, exhibiting the same viral cytopathic effect 
observed in infected PBLs, including cell death (8). Only the 
pNL4-3 DNA construct was infectious after its introduction 
into A3.01 cells (Fig. 2). Syncytia were visualized in cultures 
transfected with pNL4-3 DNA a s  early a s  day 9. This was 
followed by a peak of RT activity on day 16, a s  well as  by a 
profound reduction in the number of viable cells. pNL3-2 
DNA failed to  elicit any cytopathic effect o r  RT activity after 
its electroporation into A3.01 cells. Because pNL3-2 con- 
tained the same 5'  5.7 kb of AIDS RV sequences present in 
the infectious plasmid pNL4-3, an alteration affecting viral 
sequences mapping 3' to  the EcoRI joint most likely explains 
the loss of biological activity. 
Transfection of the infectious molecular clone of the AIDS 
RV into nonhuman T cells. Viral infectivity studies indicate 
that, with few exceptions (24, 27), the AIDS RV can only be 
propagated in the Leu-3-OKT4 helper-inducer subset of 
human T lymphocytes. This selective cell tropism most 
likely reflects the interaction of AIDS RV particles with a 
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FIG. 1. Construction of full-length clones of AIDS RV. Integrated NY5 and LAV proviruses were cloned in A Charon 4A (ANSI) or AJ1 
(AL3 and AL4), respectively (A). The EcoR1 inserts of AL3 (both orientations) and AL4 were introduced into the EcoRl site of plasmid pN5' 
DNA, which contained the BamH1-EcoRI segment from AN5' (see Materials and Methods) (B). Only inserts are shown. A schematic diagram 
of AIDS proviral DNA is shown at the top of the figure. Abbreviations: B, BumH1; E, EcoR1; H, HincII; K,  KpnI. 
specific receptor(s) (7, 21, 26) on the surface of CD4+ 
lymphocytes. However, intracellular restriction involving, 
for example, the activity of viral promoter o r  enhancer o r  the 
assembly of viral proteins and genomic RNA into infectious 
virions has not been formally ruled out. The existence of 
such an intracellular block could readily be evaluated with 
an infectious clone of the AIDS provirus, since the barrier 
Days after transfect~on 
FIG. 2. Kinetics of virus infection after transfection of A3.01 
cells. On day 0, pNL4-3 (a), pNL3-2 (A) ,  or pNL3-1 (W) was 
introduced into A3.01 cells by electroporation, and lo6 viable cells 
were placed in culture. The number of viable cells in the culture 
(-)and RT activity (- - -) were monitored on the days indicated. 
imposed by a specific cell receptor would no longer be a 
factor. 
pNL4-3 DNA was introduced into the 16 non-T cell lines 
listed in Table 1, which included both human and nonhuman 
cells. Because none of these transfected cells would be 
expected to express the putative receptor for the AIDS RV, 
it seemed very unlikely that progeny, virus particles pro- 
duced as a result of the initial transfection, would reinfect 
other cells in the culture. Because insufficient numbers of 
virions would be generated to  be detected directly by the RT 
assay, CD4' A3.01 cells were added to the cultures 48 h 
after transfection to amplify any virions that appeared. The 
presence of virus was monitored by RT assays at various 
times after cocultivation. Of the 16 non-T cell lines, 13 
yielded infectious AIDS RV particles as  a consequence of 
transfection with pNL4-3 DNA (Fig. 3 and Table 1). In most 
cases, the peak of RT activity was detected 14 to 16 days 
after transfection (12 to 14 days after cocultivation with 
A3.01 cells); cocultures of COS-1 (monkey) and SK-OV-3 
(human ovarian carcinoma) cells exhibited more rapid kinet- 
ics of virus production. A repeat of the experiment depicted 
in Fig. 3 gave similar results. In a parallel experiment that 
omitted cocultivation with A3.01 cells, no RT was detected. 
To  rule out the possibility that the non-T cell lines might 
harbor a cryptic lymphotropic virus with RT activity, each 
was cocultivated with A3.01 cells for 4 weeks; no infectious 
virus was detected. In addition, when the noninfectious 
molecular clone of the AIDS RV, pNL3-1, was transfected 
into each of the cell lines listed in Table 1 ,  no infectious 
virions were generated, even after 4 weeks of coculture. 
We were interested in ascertaining whether the progeny, 
virus particles synthesized in non-T cells, entered A3.01 
cells by cell-to-cell transfer o r  whether they budded into the 
tissue culture medium and subsequently adsorbed to viral 
receptors on the CD4+ target cells. Cell-free supernatants 
obtained from eight (A204, CAPAN-1, CaCO-2, HT-29, 
SK-OV-3, SW480, SW1463, COS-1) of the cell lines 48 h 
after transfection and prepared by filtration of tissue culture 
medium through 0.45-km-pore membranes were used to 
infect phytohemagglutinin-stimulated PBLs.  Infectious 
AIDS RV was present in all of the supernatants tested, with 
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Days after transfection 
FIG. 3. Kinetics of R? activity in transfected cells cocultivated with A3.01 cells. On day 2 after transfection with the infectious molecular 
clone pNL4-3, loh cells were cocultured with loh A3.01 cells, and RT activity was monitored on the days indicated. See Table 1 for the 
description of each cell line. 
peaks of RT detected 5 to 14 days after infection of the PBLs 
(Table 1). No virus was detected when the supernatants of 
mock-infected cultures were examined. 
Replication of the AIDS RV in non-T cells was also 
monitored by in situ hybridization. Viral RNA was readily 
detected in the A204 rhabdomyosarcoma cell line 2 days 
after transfection (Fig. 4A). RNase treatment of the 
transfected cell preparation before hybridization reduced the 
signal to background levels (zero to two grains per cell). 
Assuming that five grains above background (seven or more 
grains per cell) indicated the presence of AIDS RV RNA, 
approximately 6.7% of the A204 cells were synthesizing viral 
RNA 48 h after transfection. The number of cells expressing 
viral RNA fell precipitously thereafter, to 0.2% on day 3 and 
to 0 (out of lo5 A204 cells examined) on day 7. The recovery 
of virus by cocultivation with A3.01 cells on days 2 and 3 but 
not on day 7 (data not shown) is consistent with these in situ 
hybridization results. Similar transient expression of AIDS 
RV RNA was observed in BJAB, SW480, and NIH 3T3 cells 
transfected with pNL4-3 DNA (data not shown). 
Failure to obtain a chronic AIDS RV-producing line. Be- 
cause the non-T cell lines listed in Table 1, which synthe- 
sized infectious virus particles after transfection, apparently 
lacked the receptor(s) that would permit the initial burst of 
virions to spread throughout the culture, the possibility 
existed that cells continuously producing virus might be 
isolated from the mass culture of the transfected cells. 
Therefore, A204 cells were cotransfected with pSV2NEO 
and pNL4-3 DNAs (in a molar ratio of 1:10, respectively), 
and G418-resistant cells were selected as described previ- 
ously (35). In a companion experiment, no G418-resistant 
clones were obtained from mock-transfected cells. None of 
the 92 G418-resistant cell clones that were isolated during a 
3-week period synthesized infectious AIDS RV after 
cocultivation with A3.01 cells. This result suggested that the 
resistant A204 cells, although containing the pSV2NEO 
gene, harbored either a defective copy or no proviral DNA. 
This finding also raised the possibility that nonlymphoid cells 
undergoing productive infection with the AIDS virus may 
also be killed in the process. 
Identification of a human cell line that is exquisitely sensitive 
to transfection by cloned AIDS RV proviral DNA. During the 
examination of cell-free filtrates obtained from nonlymphoid 
cells transfected with the infectious clone of the AIDS 
provirus, we observed that one of the supernatants con- 
tained high levels of RT activity. A more careful evaluation 
of the human colon carcinoma cell line SW480 revealed that 
substantial amounts of RT activity were detectable 24 h 
posttransfection (Fig. 5); these levels gradually fell to back- 
ground levels over a 3-week period. When the experiment 
depicted in Fig. 5 was monitored by in situ hybridization, 25 
and 19% of the transfected SW480 cells were found to be 
synthesizing viral RNA on days 1 and 2, respectively (Fig. 
4B). In comparison with a cloned human CD4' lymphocyte 
cell line (S. Koenig, unpublished data) productively infected 
with the AIDS RV (Fig. 4D), SW480 cells, expressing viral 
gene products, contained two to five times more grains. 
We considered the possibility that the unique susceptibil- 
ity of SW480 cells to cloned AIDS RV proviral DNA might 
represent a more global sensitivity to DNA transfection. 
Therefore, pSV2CAT DNA was introduced into the seven 
cell lines indicated in Table 2; conversion of chlorampheni- 
col to its acetylated form, as well as DNA uptake, was 
measured in each case. When normalized for DNA uptake, 
SW480 cells were at least five times more efficient in CAT 
gene expression than any of the other cells lines examined. 
FIG. 4. In situ hybridization of cells transfected with the infectious molecular clone of the AIDS RV. A-204 (A) and SW480 (B) cells were 
subjected to in situ hybridization 48 h after transfection with pNL4-3 DNA. Mock-transfected A-204 (C) and LAV-infected CD4+ lymphocyte 
(D) cells are also shown. Magnification in panels A, B, and C, ~100; magnification in panel D, ~ 4 0 0 .  
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Days After Transfection 
FIG. 5. Kinetics of RT activity in SW480 cells transfected with 
the infectious clone pNL4-3. On day 0, 3 x lo6 SW480 cells were 
transfected with the infectious clone pNL4-3 by the calcium phos- 
phate precipitation method, and RT activity in the tissue culture 
medium was monitored on the days indicated. and A indicate the 
results of two independent experiments. 
DISCUSSION 
A major conclusion of our experiments involving the 
transfection of an infectious molecular clone of the AIDS 
virus into several different cell lines is that the interaction of 
AIDS RV particles with their receptor(s) is clearly the 
principal determinant of cell tropism. Once this cell surface 
restriction is negotiated, viral RNA and proteins are synthe- 
sized and assembled into infectious and cytopathic virions, 
irrespective of cell type. Although this result might have 
been inferred from earlier studies which showed that the 
AIDS RV-trans-activating determinant functioned in a vari- 
ety of cell types (33), this is the first report to demonstrate 
that non-T cells of four different mammalian species are 
capable of generating infectious virus. 
Unlike the situation with the cloned provirus of HTLV-11, 
which required cotransfection and selection with G418 (6), 
infectivity with pNL4-3 DNA was observed after its intro- 
duction into the CD4+ A3.01 cells without the use of 
selective pressure. A characteristic feature of transfecting 
non-T cells with the cloned AIDS RV provirus is the 
relatively short period (usually up to 7 days) during which 
progeny are synthesized. This transient production of 
virions, shown graphically in Fig. 5, most likely reflects the 
failure of the input DNA to stably integrate into the chro- 
mosome of the transfected cells. Concatemers of the cloned 
viral DNA formed during calcium phosphate precipitation 
(16, 37) may function as pseudointegrated templates for 
AIDS RV RNA synthesis for relatively brief periods of time, 
after which they are degraded or otherwise eliminated. 
Another explanation for the transient expression of virus 
production after transfection is that cells are killed as a 
consequence of synthesizing and assembling viral gene prod- 
ucts. Proving cell death after the introduction of viral DNA 
in the systems we used is technically very difficult. At best, 
about 20% of transfected cells (in the case of SW480) were 
synthesizing viral RNA during the first 48 h after transfec- 
tion. Unlike experiments with CD4+ lymphocytes in which 
virtually all of the cells are killed by waves of newly 
synthesized virions, nonlymphocytes, dying as a result of a 
productive virus infection, would be replaced in the 
monolayer by neighboring cells lacking the receptor(s) for 
secondary infection by the progeny, AIDS RV particles, and 
would thereby escape detection. Furthermore, the failure to 
obtain G418-resistant cells that produce infectious viral 
particles after cotransfection with pSV2NEO and pNL4-3 
DNAs is certainly consistent with the death of nonlym- 
phocytes expressing AIDS RV gene products. 
Transfection of the cloned AIDS RV provirus resulted in 
virus production in 13 of the 16 non-T cells examined. The 
three instances in which no virus was detected should not be 
presently viewed as examples of intracellular restriction. 
Although no virus was generated after the introduction of the 
infectious clone into Raji cells, a second B-lymphocyte line 
(BJAB) synthesized replication-competent virions (Table 1). 
Factors associated with the transfection assay per se, such 
as the efficiency of DNA uptake, could very likely be 
responsible for the failure to detect virus particles in all of 
the cell lines examined. 
A by-product of these investigations was the discovery of 
a human colon carcinoma cell line that was particularly 
sensitive to transfection. AIDS RV virions were demonstra- 
ble in cultures of SW480 cells 24 h posttransfection, thereby 
obviating the necessity for cocultivation with CD4+ target 
cells. This susceptibility to transfection also extended to 
non-RV DNAs in experiments involving pSV2CAT DNA. 
At the present time, we have no explanation for this unique 
property of SW480 cells. Certainly, the augmented expres- 
sion of transfected DNA is not due to increased DNA uptake 
(Table 2), nor is it a characteristic feature of colon carcinoma 
cells, since four other cell lines (Table 1) failed to exhibit this 
property of SW480 cells. 
We (3) and others (17, 25, 32, 38) have noted that the 
genomic heterogeneity of the AIDS RV genome affects 
primarily env gene sequences. Because the studies described 
in this report demonstrate that the main determinant of cell 
tropism involves the interaction of the viral envelope and 
cell receptor(s), it is tempting, from an evolutionary view- 
point, to link env variability to the appearance of the AIDS 
virus as a human pathogen. Stripped of its capsid and 
envelope proteins, the cloned viral DNA was expressed as 
TABLE 2. Relative CAT activity in cells transfected with 
pSV2CAT 
Cell line Description %Con-  DNA CAT 
versiono uptakeb activityC 
SW480 Human colon cells 83.0 1.0 100 
SK-CO-1 Human colon cells 6.8 1.2 7 
SK-OV-3 Human ovarian cells 33.8 2.0 20 
CAPAN-1 Human pancreatic cells 10.2 0.7 18 
A-204 Human rhabdomyosarcoma 3.2 1.1 4 
cells 
HMB2 Human melanoma cells 0.5 0.2 3 
NIH 3T3 Mouse fibroblasts 0.7 0.8 1 
p~ 
" CAT assays were done with equivalent amounts of protein from each cell 
lysate (100 kg per assay).  After analysis by ascending thin-layer 
chromotography, the rates of conversion were determined by scintillation 
counting. CAT activity of mock-transfected cell lysates was less than 0.1%. 
DNA uptake was determined by dot blot hybridization using "P-labeled 
pUC18 DNA. Membranes were subsequently monitored in a liquid scintilla- 
tion counter, and DNA uptake was normalized relative to that of SW480 cells. 
The counts hybridized per minute varied from 2,338 (HMB2) to 29.700 
(SK-OV-3); mock-transfected cultures contained less than 200 cpm. 
CAT activity was normalized for conversion and DNA uptake relative to 
that of SW480 cells. 
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infectious virus in virtually all cells tested.  One  could 
propose  tha t  a n  alteration more  profound than is  normally 
observed in t he  env region o f  different AIDS RV isolates 
drastically alters t h e  cell and  species target o f  a progenitor t o  
t he  A I D S  virus.  In  t he  process ,  such a virus could lose its 
original tropism and  a s sume  a new ecological niche: the  
helper a n d  inducer CD4+ lymphocytes o f  humans .  
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